Head to Head Comparison: Nature’s Sunshine Products (NASDAQ:NATR) versus Q BioMed (NASDAQ:QBIO)
Nature’s Sunshine Products (NASDAQ:NATR) and Q BioMed (OTCMKTS:QBIO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends.
This table compares Nature’s Sunshine Products and Q BioMed’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Nature’s Sunshine Products||0.77%||4.65%||2.76%|
This table compares Nature’s Sunshine Products and Q BioMed’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Nature’s Sunshine Products||$364.81 million||0.53||-$850,000.00||N/A||N/A|
|Q BioMed||N/A||N/A||-$9.27 million||($0.67)||-3.10|
Nature’s Sunshine Products has higher revenue and earnings than Q BioMed.
Volatility and Risk
Nature’s Sunshine Products has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Q BioMed has a beta of 5.31, suggesting that its stock price is 431% more volatile than the S&P 500.
This is a summary of current ratings and target prices for Nature’s Sunshine Products and Q BioMed, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Nature’s Sunshine Products||0||0||0||0||N/A|
Institutional and Insider Ownership
76.6% of Nature’s Sunshine Products shares are held by institutional investors. Comparatively, 0.0% of Q BioMed shares are held by institutional investors. 20.3% of Nature’s Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Nature’s Sunshine Products beats Q BioMed on 8 of the 10 factors compared between the two stocks.
Nature’s Sunshine Products Company Profile
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide. It operates through four segments: NSP Americas; NSP Russia; Central and Eastern Europe; and NSP China. The company offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. It also provides immunity, cardiovascular, and digestive products; and personal care products, including oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpastes, and skin cleansers, as well as weight management products. The company offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent managers and distributors. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Q BioMed Company Profile
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; BM-001 for the treatment of rare pediatric nonverbal autism spectrum disorder; and Uttroside-B for liver cancer. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was founded in 2013 and is based in New York, New York.
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.